SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001370053-20-000019
Filing Date
2020-04-27
Accepted
2020-04-27 16:02:56
Documents
6
Period of Report
2020-06-19
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxystatementfy2019.htm DEF 14A 649101
2 a2019proxycard2a01.jpg GRAPHIC 127578
3 a2019proxycarda01.jpg GRAPHIC 145810
4 hssignature1a02.jpg GRAPHIC 72893
5 jtsignature1a02.jpg GRAPHIC 58580
6 logoa04.jpg GRAPHIC 13939
  Complete submission text file 0001370053-20-000019.txt   1210737
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37985 | Film No.: 20819932
SIC: 2834 Pharmaceutical Preparations